Status:
COMPLETED
TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000
Lead Sponsor:
Topcon Medical Systems, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Brief Summary
To determine optimal cut-off value for the TopQ cut-off on the Maestro and 3D OCT-2000.
Eligibility Criteria
Inclusion
- No known ocular pathologies
Exclusion
- Any known ocular pathologies
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT02203981
Start Date
January 1 2014
End Date
August 1 2014
Last Update
June 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Topcon Medical Systems, Inc.
Oakland, New Jersey, United States, 07436